Standard
Ulcerative colitis following B lymphocyte depletion with rituximab in a patient with Graves' diseaseTumor necrosis factor-alpha binding capacity and anti-infliximab antibodies measured by fluid-phase radioimmunoassays as predictors of clinical efficacy of infliximab in Crohn's disease. / El, Fassi D.; Kjeldsen, J.; Clemmensen, O.; Hegedus, L.; Nielsen, Claus Henrik.
In:
Gut, Vol. 57, No. 5, 2008, p. 714-715.
Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
El, FD, Kjeldsen, J, Clemmensen, O, Hegedus, L & Nielsen, CH 2008, 'Ulcerative colitis following B lymphocyte depletion with rituximab in a patient with Graves' diseaseTumor necrosis factor-alpha binding capacity and anti-infliximab antibodies measured by fluid-phase radioimmunoassays as predictors of clinical efficacy of infliximab in Crohn's disease', Gut, vol. 57, no. 5, pp. 714-715.
APA
El, F. D., Kjeldsen, J., Clemmensen, O., Hegedus, L., & Nielsen, C. H. (2008). Ulcerative colitis following B lymphocyte depletion with rituximab in a patient with Graves' diseaseTumor necrosis factor-alpha binding capacity and anti-infliximab antibodies measured by fluid-phase radioimmunoassays as predictors of clinical efficacy of infliximab in Crohn's disease. Gut, 57(5), 714-715.
Vancouver
El FD, Kjeldsen J, Clemmensen O, Hegedus L, Nielsen CH. Ulcerative colitis following B lymphocyte depletion with rituximab in a patient with Graves' diseaseTumor necrosis factor-alpha binding capacity and anti-infliximab antibodies measured by fluid-phase radioimmunoassays as predictors of clinical efficacy of infliximab in Crohn's disease. Gut. 2008;57(5):714-715.
Author
El, Fassi D. ; Kjeldsen, J. ; Clemmensen, O. ; Hegedus, L. ; Nielsen, Claus Henrik. / Ulcerative colitis following B lymphocyte depletion with rituximab in a patient with Graves' diseaseTumor necrosis factor-alpha binding capacity and anti-infliximab antibodies measured by fluid-phase radioimmunoassays as predictors of clinical efficacy of infliximab in Crohn's disease. In: Gut. 2008 ; Vol. 57, No. 5. pp. 714-715.
Bibtex
@article{b9c79140986b11de8bc9000ea68e967b,
title = "Ulcerative colitis following B lymphocyte depletion with rituximab in a patient with Graves' diseaseTumor necrosis factor-alpha binding capacity and anti-infliximab antibodies measured by fluid-phase radioimmunoassays as predictors of clinical efficacy of infliximab in Crohn's disease",
abstract = "Udgivelsesdato: 2008/5",
author = "El, {Fassi D.} and J. Kjeldsen and O. Clemmensen and L. Hegedus and Nielsen, {Claus Henrik}",
year = "2008",
language = "English",
volume = "57",
pages = "714--715",
journal = "Gut",
issn = "0017-5749",
publisher = "B M J Group",
number = "5",
}
RIS
TY - JOUR
T1 - Ulcerative colitis following B lymphocyte depletion with rituximab in a patient with Graves' diseaseTumor necrosis factor-alpha binding capacity and anti-infliximab antibodies measured by fluid-phase radioimmunoassays as predictors of clinical efficacy of infliximab in Crohn's disease
AU - El, Fassi D.
AU - Kjeldsen, J.
AU - Clemmensen, O.
AU - Hegedus, L.
AU - Nielsen, Claus Henrik
PY - 2008
Y1 - 2008
N2 - Udgivelsesdato: 2008/5
AB - Udgivelsesdato: 2008/5
M3 - Journal article
VL - 57
SP - 714
EP - 715
JO - Gut
JF - Gut
SN - 0017-5749
IS - 5
ER -
